DEREK JANTZ - 17 May 2021 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Scientific Officer, Director
Signature: /s/ Dario Scimeca, Attorney-in-Fact for Derek Jantz
Issuer symbol: DTIL
Transactions as of: 17 May 2021
Net transactions value: -$187,600
Form type: 4
Filing time: 19 May 2021, 08:44:21 UTC
Previous filing: 18 May 2021
Next filing: 09 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	DTIL	Common Stock	Sale	$187,600	-20,000	-0.49%	$9.38	4,032,279	17 May 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale was effected to cover the taxes incurred with the Reporting Person's previous option exercise.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.21 to $9.63. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Content

The sale was effected to cover the taxes incurred with the Reporting Person's previous option exercise.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.21 to $9.63. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.